18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)

BMC Cancer. 2021 Sep 10;21(1):1015. doi: 10.1186/s12885-021-08748-x.

Abstract

Background: Graft versus host disease (GvHD) is a frequent complication of allogeneic stem cell transplantation (alloSCT), significantly increasing mortality. Previous imaging studies focused on the assessment of intestinal GvHD with contrast-enhanced MRI/CT or 18F-FDG-PET imaging alone. The objective of this retrospective study was to elucidate the diagnostic value of a combined 18F-FDG-PET-MRI protocol in patients with acute intestinal GvHD.

Methods: Between 2/2015 and 8/2019, 21 patients with acute intestinal GvHD underwent 18F-FDG-PET-MRI. PET, MRI and PET-MRI datasets were independently reviewed. Readers assessed the number of affected segments of the lower gastrointestinal tract and the reliability of the diagnosis on a 5-point Likert scale and quantitative PET (SUVmax, SUVpeak, metabolic volume (MV)) and MRI parameter (wall thickness), were correlated to clinical staging of acute intestinal GvHD.

Results: The detection rate for acute intestinal GvHD was 56.8% for PET, 61.4% for MRI and 100% for PET-MRI. PET-MRI (median Likert-scale value: 5; range: 4-5) offers a significantly higher reliability of the diagnosis compared to PET (median: 4; range: 2-5; p = 0.01) and MRI alone (median: 4; range: 3-5; p = 0.03). The number of affected segments in PET-MRI (rs = 0.677; p < 0.001) and the MV (rs = 0.703; p < 0.001) correlated significantly with the clinical stage. SUVmax (rs = 0.345; p = 0.14), SUVpeak (rs = 0.276; p = 0.24) and wall thickening (rs = 0.174; p = 0.17) did not show a significant correlation to clinical stage.

Conclusion: 18F-FDG-PET-MRI allows for highly reliable assessment of acute intestinal GvHD and adds information indicating clinical severity.

Keywords: FDG; GvHD; Inflammation; PET-MRI.

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Allografts
  • Female
  • Fluorodeoxyglucose F18*
  • Graft vs Host Disease / diagnostic imaging*
  • Humans
  • Intestinal Diseases / diagnostic imaging*
  • Magnetic Resonance Imaging / methods*
  • Magnetic Resonance Imaging / statistics & numerical data
  • Male
  • Middle Aged
  • Multimodal Imaging / methods*
  • Multimodal Imaging / statistics & numerical data
  • Positron-Emission Tomography / methods*
  • Positron-Emission Tomography / statistics & numerical data
  • Radiopharmaceuticals*
  • Reference Standards
  • Reproducibility of Results
  • Retrospective Studies
  • Stem Cell Transplantation / adverse effects
  • Whole Body Imaging / methods

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18